Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00665418Phase 4Terminated
Phase 4, open-label trial of sevoflurane in laryngospasm, sponsored by University Hospital Basel. Primary endpoint: Occurrence of laryngospasm. Started Feb 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00665418.